Indacaterol (INN) is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30 2009 and by the United States Food and Drug Administration (FDA) under the trade name Arcapta Neohaler on July 1 2011. It needs to be taken only once a day unlike the related drugs formoterol and salmeterol.
This page contains content from the copyrighted Wikipedia article "Indacaterol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
-Indacaterol_Structural_Formulae.svg?width=300)